Sarah Kang

Statistics

Publications

Citations

H-Index

Active since

2017

Affiliations

United States Food and Drug Administration(Current)

Sarah Kang is an author at United States Food and Drug Administration specializing in pharmacotherapy, drug-induced liver injury biomarkers, and women's health pharmacotherapy.

ORCID

Publications per year

2017–2020

Publications

Etonogestrel implant migration to the vasculature, chest wall, and distant body sites: cases from a pharmacovigilance database

Sarah Kang, Ali Niak, Neha Gada et al. · Contraception · 2017 · 33 citations

Dentistry, Endocrinology, Pharmacotherapy +13

An Evaluation of Postmarketing Reports of Serious Idiosyncratic Liver Injury Associated with Ulipristal Acetate for the Treatment of Uterine Fibroids

Sarah Kang, Allen Brinker, S. Christopher Jones et al. · Drug Safety · 2020 · 18 citations

Pharmacy, Pharmacotherapy, Toxicology +16

1–2 of 2